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Abstract
Quantizationof gene expression requiresthatan accuratemeasurementof a specifictranscriptismade.Inthis
paper, a quantitative reverse transcription-polymerase chain reaction (RT-PCR) by competition for tilapia
growthhormonereceptortypeIisdesignedandvalidated.Thisexperimentalprocedurewasusedtodetermine
the abundance of growth hormone receptor type I transcript in different tilapia tissues. The results obtained
with thisdeveloped competitiveRT-PCR were similar toreal-timePCR results reported recently.Thisproto-
col provides a reliable alternative, but less expensive than real-time PCR to quantify specific genes.
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RNA Ribonucleic acid
RT Reverse transcription
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tiGHR I Tilapia growth hormone receptor type I
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791. Introduction
Growth hormone (GH) plays a central role as a pluripotent endo-
crine regulator of physiological functions in fish and higher verte-
brates, working through specific cell membrane receptor (GHR)
that triggers a phosphorylation cascade for signaling and gene ex-
pression events (1, 2). The nucleotide sequence of GHR is available
for mammals, birds, reptiles, and Xenopus. Based on conserved
structural features, these receptors belong to class I cytokine recep-
tor superfamily that include, among others, receptors for prolactin,
erythropoietin, granulocyte colony stimulating factor, and several
interleukins (3). Since the initial cloning and sequence of goldfish
(Carassius auratus)( 4) and turbot (Scophthalmus maximus)( 5)
GHRs, other fish GHRs have been characterized in black sea
bream (Acanthopagrus schlegeli)( 6), gilthead sea bream (Sparus
aurata)( 7), masu salmon (Oncorhynchus masou)( 8), rainbow trout
(Oncorhynchus mykiss)( 9), catfish (Silurus meridionalis), and tilapia
(Oreochromis niloticus)( 10). Amino acid alignment of full-length
GHRs reveals a relative high degree of identity (35–40%) among tet-
rapodsandnon-salmonidfishGHRs(GHRtypeI).Severalauthors
have postulated a divergent evolution of salmonid GHRs (GHR
type II); however, it has recently been cloned a GHR in rainbow
trout (Oncorhynchus mykiss), which is analogous to GHRs of
non-salmonid fish (GHR type I) and a GHR type II in non-salmo-
nid fish (11). Duplicated fish GHRs represent a new and perhaps
complexstepontheregulationoffishsomatotropicaxis.Inthissce-
nario, accurate measurements of both GHR expression patterns in
different tissues and in different physiological stages are necessary.
The classic methods to do this, such as Northern blots and RNAse
protection assay, have been improved over the years and have pro-
vided reliable results. However, they share the weakness of having
too low sensitivity among other drawbacks. Because of its extreme
sensitivity, the polymerase chain reaction (PCR) has the potential
to detect and precisely quantify specific RNA sequences if it is
used in combination with reverse transcription. However, the re-
petitive multiplication of template molecules is a drawback for
quantitative measurements because small differences in the mul-
tiplication factor lead to large differences in the amount of prod-
uct (12). Although the use of PCR for quantification has been
uncritically accepted by many scientists, it really cannot be relied
upon for quantitative measurements. Two methods can be used
to solve the problem of quantification: kinetic methods and co-
amplification methods. Co-amplification methods can be done
without expensive equipment. In this study, we design a com-
petitor molecule to quantify accurately the tilapia growth hor-
mone receptor type I (tiGHR I) in different tilapia tissues
80 Rodríguez-Mallon et al.using a quantitative RT-PCR by competition and we show that
it is sensitive, reproducible, and robust.
2. Materials
and Methods
2.1. Cloning a TiGHR I
Probe
We designed four forward degenerate oligonucleotides (A, B, C,
and D) that contained all the coding sequences for a conserved N
glycosilation site of the GHR extracellular domain (LNWTLLNI)
and four reverse degenerate oligonucleotides (E, F, G, and H) that
contained all the coding sequences corresponding to the proline-
rich site in the intracellular domain box I (PKIKGIDP) (Table 1).
Total RNA from tilapia liver (O. niloticus) was obtained by
the acid phenol method (13). Messenger RNA was purified from
total RNA using the “PolyAtract® mRNA Isolation System III”
kit (Promega, USA). Messenger RNA was reverse transcribed with
oligo (dT) 15 using “Reverse Transcription System” (Promega).
Polymerase chain reactions were set up in 50-μl volumes using
“PCR Master Mix” (Promega) with 3 μM of forward and reverse
primers and 1/10 volume of the RT reaction. We used all possible
combinations of the degenerated oligonucleotides (16 different
reactions). The PCR condition used 95°C for 3 min, followed by
a cycling program of 94°C for 1 min, 42°C for 1 min and 72°C
for 1 min for 30 cycles, and a final extension at 72°C for 5 min.
PCR products were purified from agarose gel using “Qiaquick®
Gel Extraction” Kit (Qiagen, USA) and cloned in T-vector
Table 1
Forward and reverse degenerate oligonucleotides to clone tiGHR I probe
Oligonucleotides Sequences
A5 ′…(tc)t(ag)aa(ct)tggac(acgt)(tc)t(ag)tt(ag)aa(ct)at…3′
B5 ′…ct(tc)aa(ct)tggac(acgt)tt(ag)(ct)t(ag)aa(ct)at…3′
C5 ′…(ct)t(ag)aa(ct)tggac(acgt)ct(tc)ct(tcag)aa(tc)at…3′
D5 ′…ct(tc)aa(ct)tggac(acgt)ct(tcag)ct(tc)aa(tc)at…3′
E5 ′…gg(ga)tc(tag)at(tg)cc(tc)tt(tga)at(tc)tt(tg)gg…3′
F5 ′…gg(ga)tc(tga)at(tg)cc(tc)tt(tga)at(tc)tt(ca)gg…3′
G5 ′…gg(ga)tc(tag)at(ca)cc(tc)tt(tga)at(tc)tt(tg)gg…3′
H5 ′…gg(ag)tc(tag)at(ca)cc(tc)tt(tga)at(tc)tt(ca)gg…3′
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were sequenced using standard techniques (14).
2.2. Generation
of Competitor
Starting with a clone containing an insert of 458 bp of tiGHR I
(Probe), we did two subcloning steps to obtain an internal duplica-
tion of 100 bp respect to original fragment, generating a fragment
used as competitor (Fig. 1). The competitor was linearized with
the endonuclease Sma I and transcribed in vitro using “T7 Ribo-
MAX Express RNAi System” kit (Promega) to obtain the compet-
itor RNA.
2.3. Competitive PCR Wedesignedtwospecificoligonucleotides(I=ccccacctactgctgatgttag
and J=caggaacaggcggcagcagg) that hybridize inside to the fragment
ofthetiGHRgeneclonedbetweenbindingsitesofdegenerateoligo-
nucleotides. When we use these specific oligonucleotides in a PCR,
we generate a 366 bp amplification product from the wild-type
DNA (T-target) and a 473 bp amplification product from the com-
Fig. 1. Design for the isolation of probe from the tiGHR I cDNA and construction of competitor frag-
ment to use in quantitative PCR. a Diagram of probe amplification from the tiGHR I cDNA using de-
generate oligonucleotide B and E. ECD, extracellular domain; TMD, transmembrane domain; ICD,
intracellular domain; black box 1, conserved N glycosilation site of the GHR extracellular domain
(LNWTLLNI); black box 2, coding sequences corresponding to the proline-rich site in the intracellular
domain box I (PKIKGIDP); Probe, 458-bp DNA fragment of tiGHR I obtained with the B–E oligonucle-
otide mixes and cloned in Easy T-vector (shadow boxes); Competitor, 473 DNA fragment obtained from
two subcloning steps to produce a tandem of two copies of the Pst I–Acc I fragment of the Probe; I
and J, internal oligonucleotide from the probe fragment designed for the amplification of target and
competitor; E, EcoR I; P, Pst I; A, Acc I; S, Sac I. b 2% agarose gel image with the PCR amplification
products using oligonucleotides I and J: 1, PCR negative control (without template); 2, PCR using a
RT reaction from tilapia liver mRNA as template; 3, PCR using competitor sequence as template, 4,
PCR using probe as template.
82 Rodríguez-Mallon et al.petitor DNA (Ccompetitor) (Fig. 1b). The PCR reactions were set
up in 50 µl with “PCR Master Mix” and 0.2 µM of each primer.
We used a denaturalization step of 95°C for 2 min, followed by a cy-
clingprogramof94°Cfor30s,62°Cfor30s,and72°Cfor1minfor
30 cycles. A PCR negative control was set up for all the PCR batches
toascertaintheauthenticityofPCR.Theamplificationproductswere
resolved in 2% agarose gels with ethidium bromide. Gel images were
obtained using a digital camera Olympus C7070 Wide Zoom. The
photos saved in jpeg format were used for densitometry analysis.
2.4. Quantitative
Analysis
The densitometry data for band intensities in different sets of
experiments was generated by analyzing the gel images on the
Image J program (Version 1.33, USA). Previously to the experi-
ments of competitive PCR, we did an experiment (data not
shown) to control the consistency of our densitometry raw data.
Because of the low dynamic range of ethidium bromide gels, it
is necessary to control if the peak areas corresponding to densi-
tometry values obtained by Image J program reproduce really
the band intensities. In this experiment, we used a wide range of
concentration of DNA and considered the relation dose–response.
The lineal relation is lost after 100 ng of DNA.
2.5. Determination
of Target/competitor
AmplificationEfficiency
Ten identical PCR mixtures were prepared, as described above,
each containing 100,000 molecules of target and competitor
DNA. The PCR cycling conditions were carried through 45 cycles
with one tube being removed after 17, 19, 21, 24, 27, 30, 33, 36,
39, and 45 cycles and the amount of the PCR products quanti-
fied. Procedure was repeated two times. Efficiency was calculated
as Ei ¼ Pi   Pi   1 ðÞ =Pi   1( 12), where Ei is the efficiency in one
step, Pi is the quantity of product in that step, and Pi−1i st h e
product already accumulated during the previous step. The effi-
ciency means for target and competitor in each cycle were com-
pared using matched t test.
2.6. Determination
of Accuracy
of the Competitive PCR
To test the precision of the results obtained with this competitive
PCR, five different amounts of T (10,000, 100,000, 150,000,
200,000, and 1,000,000 molecules) were assayed with serial dilu-
tions of the C. Each set of validation experiments comprised at
least four reaction combinations (T related to C) with three rep-
licas for each point in the conditions described above. One of
these experiments (100,000 molecules of target with six compet-
itor dilutions with three replicas of each point) was repeated three
times in different days. These produced a data set of 120 reactions
to address the intra- and inter-experiment variability, precision,
and resolution of our experimental system.
2.7. Sensitivity
of Competitive PCR
To test the minimum quantity of target molecules that our PCR is
able to detect, we did five sets of experiments ranging from 2,000
Competitive RT-PCR Strategy 83until 10 molecules of target with three different dilutions of com-
petitor with two replicas for each point in the conditions set up
above.
2.8. Competitive
RT-PCR
To determine the tiGHR I expression levels in different tilapia
tissues, we started from total RNA mini-preparations of each tis-
sue using the acid phenol method (13). We used three juvenile
tilapias (O. niloticus) of 100 g as source of 100 mg of tissue from
liver, muscle, brain, heart, stomach, spleen, intestine, and gonads.
The RT-PCR reactions were done using “Ready-To-Go™ RT-
PCR Beads” (Amersham Biosciences, USA) using the same
cycling profile described before. For each sample of total RNA,
we used at least two known different quantities of competitor
RNA molecules to obtain linear regressions. We determined the
number of target molecules in the sample when log (T/C) equals
zero (15). In this way, the target molecules number for all tissue
samples of each tilapia was obtained. These values were normalized
versus total RNA (RNAt) used to do the RT reaction. The same
quantity of RNAt used in the RT reaction was electrophoresed
on 1.5% formaldehyde agarose gel. The densitometry data of the
bands corresponding to the 28S subunits measured with Image J
program were converted to micrograms of RNAt using a reference
RNAt with known concentration. Then, the results were expressed
as number of tiGHR I molecules/µg RNAt. The obtained averages
of the tiGHR I molecules/µg RNAt for each tissue were compared
by non-parametric Kruskal–Wallis test followed by Dunn multiple
comparison test (Prism, version 4.0 for Windows; GraphPad
Software, USA).
3. Results
3.1. Cloning TiGHR I
Probe, Construction
of Competitor,
and Verification
of Differentiable
Amplification
The combination between the four forward degenerated oligonu-
cleotides (A, B, C, and D) and the four reverse degenerated oli-
gonucleotides (E, F, G, and H) give 16 different PCRs. The
bands nearby 500 bp were cloned in T-vector and sequenced.
One clone (probe) with a 458 bp fragment of tiGHR I was
obtained with the B–E oligonucleotide mixes (Fig. 2). This frag-
ment is 100% identical to the reported GHR type I from tilapia
(O. niloticus) (accession number AY973232), without the se-
quence of the degenerated oligonucleotides. After the competitor
construction, we were able to see a difference in the electropho-
retic mobility between the amplification products of wild-type
and competitor sequences of tiGHR I using I and J oligonucleo-
tides in the PCR (Fig. 1b).
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of Equal Amplification
Efficiencies for Target
and Competitor
Target and competitor amplify in the competitive PCR with the
same efficiency over 24–39 cycles (Fig. 3). No statistically signif-
icant differences between the cycle efficiency averages of the com-
petitor and target sequences were encountered using a paired t
test (pG0.05). All subsequent competitive PCRs were carried
out for 30 cycles, when the amplification was found to be lineal
and the efficiency was diminishing but it was equal for the target
and competitor sequences. In addition, to 30 cycles the quantity
of amplification products in our PCR conditions is sufficiently vis-
ible in an ethidium bromide gel and keeps the lineal relationship
to measured peak areas. It means that the band intensities are far
from the gel saturation point.
3.3. Accuracy
of Competitive PCR
The raw data collection of the 120 amplification reactions is given in
file1oftheElectronicsupplementarymaterial.Fivedifferentquan-
tities of the target sequence (10,000, 100,000, 150,000, 200,000,
and 1,000,000 molecules) were amplified in the presence of dilution
series of the competitor sequence. The log ratio of the quantity of
productsversusthelogofthecompetitorsequenceaddedwasplotted
(Fig. 4). The validity of the competition reaction data at different
target concentrations is represented by regression equations with
respective R
2 values. Each point in the best fitted regression line
is the average among three replicas. The calculated concentration
Fig. 2. Sequence of the probe corresponding to a 458-bp fragment of tiGHR I. In bold and underline,
oligonucleotides corresponding to mix B and E, respectively; inside box, amino acid sequences used
to design degenerated oligonucleotides.
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sequence, determined from the regression line, when the log ratio
of the products equals zero. There is a good correlation between
the observed and expected concentrations of the target sequence
characterized by a Pearson r of 0.9978 (95% CI 0.9656–
0.9999) with pG0.001 extremely significant (Table 2). Intra-
and inter-experiment repeatability was measured. The coefficients
of variation among the replicas of the experimentally determined
target concentrations in each experiment are shown in Table 3.
The experiment using 100,000 molecules of target sequence
with six different dilutions of the competitor sequence with
three replicas by each point was repeated three times in different
days. Triplicate analyses yielded an experimentally determined
quantity of target of 107,000+8,622 molecules with an inter-
experiment coefficient of variation of 8%.
3.4. Sensitivity
of Competitive PCR
Seven hundred and fifty molecules in 50 µl of PCR is the lower
limit of quantification (LLQ) of target DNA sequence that the
competitive PCR was able to detect.
3.5. Competitive
RT-PCR in Different
Tilapia Tissues
Abundance levels of tiGHR I mRNA (target) in different tilapia
tissues were measured using the quantitative RT-PCR by compe-
tition validated above. Liver RNA of three different tilapias was
assayed in the presence of different quantities of competitor
RNA. Densitometry data derived from band intensities of compet-
Fig. 3. PCR efficiencies of target and competitor. In the picture: 1, PCR negative control; amplifica-
tion products at 17, 19, 21, 24, 27, 30, 33, 36, 39, and 45 cycles corresponding to lines 2, 3, 4, 5, 6, 7,
8, 9, 10, and 11, respectively, using 10
5 molecules of competitor and target in the PCR; 12, molecular
weight marker (from top to bottom=1.4 kb, 1.2 kb, 750 bp, 450 bp, and 366 bp). Lines represent den-
sitometry data of the target and competitor band intensities versus cycle number. Each point is the
average between two different experiments. Bars represent the target and competitor PCR efficien-
cies for each cycle. There are no statistically significant differences between target and competitor
efficiencies in any cycles determined using matched t test (p90.05).
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(Fig. 5). We discarded the amplification of genomic DNA
sequences because the specific oligonucleotides I and J hybridize
to different exons, which means that, in the genomic DNA
sequences between these oligonucleotides, there are introns.
PCR amplifications from genomic DNA sequences would give
a higher size than 366 bp and 473 bp expected for target and
competitor amplifications, respectively. The quantity of specific
Fig. 4. Lineal regressions generated from the densitometry data of the PCR reaction using fixed target
moleculenumbersandserialdilutionsofcompetitor.Inthepicture,typical2%gelimageofamplification
products in the competitive PCRs where 10
5 molecules of target were used with serial dilutions of com-
petitor.1,PCRnegativecontrol;lanes2–4,10
4;lanes5–7,5×10
4;lanes8–10,7.5×10
4;lanes11–13,10
5;lanes
14–16,5×1 0
5; lanes 17–19, 7.5×10
5 molecules of competitor, respectively; 20,m o l e c u l a rw e i g h tm a r k e r
(from top to bottom=1.4 kb, 1.2 kb, 750 bp, 450 bp, and 366 bp).
Table 2
Number of the expected and observed target molecules
Number of target molecules
a
Expected Observed
10,000 11,000
100,000 107,000
150,000 146,000
200,000 290,000
1,000,000 1,180,000
aCharacterized by a Pearson r of 0.9978 (95% CI 0.9656–0.9999) with pG0.001
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band intensity of the 28S subunit of the total RNA used in
the RT reaction. The quantity of tiGHR I RNA reported here
for liver is the average of the normalized data obtained from each
tilapia. The coefficient of variation is presented in the Electronic
supplementary material 2. The procedure with the other tilapia
tissues was the same. The raw data can be seen too in file 2 of the
Electronic supplementary material. The coefficients of variation
of these experiments were between 10% and 50%. After the process-
ing of all obtained data from the selected tilapia tissues, we obtained
the profile of the expression levels of tiGHR I mRNA (Fig. 6).
Table 3
Intra-experiment variability
Expected molecules target 1,000,000 200,000 150,000
100,000
a
10,000 ABC
Observed molecules target
b 1,173,333 290,000 255,000 115,000 110,667 97,333 11,200
SD 161,658 35,000 91,788 5,000 9,292 3,055 2,081
CV 13.78% 12.07% 36% 4.35% 8.40% 3.14% 21.89%
aExperiments A, B, and C correspond to experiments developed on three different days
bEach value corresponds to the mean of three experimental replicates
Fig. 5. Determination of the quantity of tiGHR I RNA in tilapia liver. Lineal regressions with data from
three different tilapias. The picture is an example of 2% agarose gel with the amplification products
of competitive RT-PCR using total RNA from the liver of tilapia 4 and known quantities of competitor
RNA. 1, molecular weight marker (leader 100 bp, Promega); 2, RT-PCR negative control; 3, RT-PCR
with 5×10
5 molecules of RNA competitor alone; 4, RT-PCR with liver total RNA of tilapia alone; 5, 6,
and 7, RT-PCR of liver total RNA of tilapia 4 with 3×10
5,6×1 0
5, and 8×10
5 molecules of competitor,
respectively.
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The exponential character of PCR amplification may compro-
mise quantitative assays because it multiplies variations. The
competitive PCR strategy used in the present study was aimed
to overcome some of the limitations of the conventional RT-
PCR. Co-amplification methods quantify the target DNA rela-
tive to a second control sequence in the same PCR tube. The
main advantages of this technique are that the results are not
affected by tube-to-tube variations in amplification efficiency
and it is not necessary to restrict PCR to the exponential phase.
Reliable quantification is still possible if the PCR extends into
the linear phase, or even in the saturation phase, provided it
is ascertained that the amplification efficiency is the same for
both templates throughout the PCR, including the final cycles
(12, 16). Quantitativeco-amplificationrestsontheassumptionthat
theproductratiooftargetandcompetitorsequencesreliablyreflects
the ratio of their initial copy numbers. Therefore, it is requisite that
efficiency is identical for both sequences. If the target sequence (T)
and the competitor sequence (C) would amplify with the smallest
difference in this efficiencies, it can lead to very different quantities
of the end products. This can result in an erroneous estimation of
the amount of initial material [12, 16]. Figure 3 shows that the effi-
ciencies in our system for target and competitor are equal in each
cycle, even if the efficiencies decrease in the later cycles. The validity
of the competition reactions to each quantity of target was
established by the generated regression equations with their
Fig. 6. Expression of tiGHR I in different tilapia tissues. The non-parametric test of Kruskal–Wallis
followed by Dunn’s post test only detected significant differences between liver and spleen and be-
tween liver and stomachs (pG0.05).
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2 values (Figure 4). The slope of the
regression curves obtained was close to 1 in all five standard curves,
indicatingthatnodifferentialamplificationratesexistbetweenTand
Cin therangeofassayedT.Variabilityinthe10,000-to1,000,000-
molecule ranges of target sequence was determined. Coefficients of
variation according to non log-transformed absolute values were 8%
inter-assay and ranging between 3.14% and 8.4 % intra-assay for
100,000 molecules of T. CVs of 21.89%, 36%, 12.07%, and
13.78% intra-assay for 10,000, 150,000, 200,000, and 1,000,000
molecules of T, respectively were obtained (Table 3). In general,
lowertargetquantitiesgivehigherCVs.Ourvariabilityisintherange
of the variability of the PCR assay [17, 18]. In general, CVs
correspondingtoreactionconditions,inwhichthequantityoftarget
and competitor was equivalent ornearby, were under 10%, and CVs
correspondingtoreactionconditions,inwhichtheratioC/Twas10
or 1/10, were between 10% and 35%. Other authors affirm that
more time-consuming methods of RNAse protection assay and
Northern blots are more accurate and precise than RT-PCR. How-
ever, it has been reported that RNAse protection assay could detect
approximately 1 × 106 target transcripts and it has been estimated
that a Northern blot is about tenfold less sensitive than RNAse pro-
tectionassay(19), thentheyarelimitedtostudythosegenesthatare
relatively highly expressed. Our competitive PCR was able to detect
atleast750moleculesofDNAtargetsequencein50µlofPCR.Ifwe
assume 10% of efficiency of the RT reaction, the LLQ of our system
would be 7.5×10
3 target transcripts. Therefore, this assay is more
sensitive than RNase protection and Northern blot assays. Our
results show that our design of competitive PCR together with RT
reactionisusefultostudytheexpressionleveloftiGHRIindifferent
tissues of tilapia (O. niloticus). By using in vitro transcribed compet-
itor RNA, we have been able to reduce sources of variation such as
the variable efficiency of the reverse transcription reaction because
the quantity of competitor RNA molecules that we put together
with specific tissue total RNA samples is reverse transcribed with
thesameefficiencythatthemoleculesofRNAtargetineachsample.
We have also been able to detect expression of this receptor in
all studied tissues, which is consistent with the pleiotropic nature
of growth hormone in fish (20–23). The expression level of
tiGHR that we obtained for each studied tissue can be organized
in decreased order of expression levels as: liver9muscle9brain9
heart9gonads9intestine9stomach9spleen (Fig. 6). The highest
expression level of tiGHR I in liver is consistent with previous re-
ceptor binding studies (20). Besides, it is in agreement with pre-
vious conventional RT-PCR studies (4, 6) and with real-time
PCR studies (24). As it is expected, the tissue distribution obtained
for us is more similar to the real-time RT-PCR results than to the
results of the other studies using conventional RT-PCR. The fact
that we observed statistically significant differences only between
90 Rodríguez-Mallon et al.liver–spleen and between liver–stomachs is due to a non-para-
metric test that we used. These tests are less powerful than
the parametric tests that assume data Gaussian distributions.
With small samples (n=3), non-parametric tests have little pow-
er to detect differences especially when we work with biological
samples that are intrinsically variable. In future experiments, we
will work with a higher number of animals. To refine our ini-
tially found results, we would retest them with a higher resolu-
tion of competitor molecules because we demonstrate in the
validation experiments that the coefficients of variability are
lower when the molecule numbers of target and competitor
sequences in the samples are similar.
Despite the fact that the described competitive RT-PCR assay
is labor intensive, less sensitive, and has a lower dynamic range
than the real-time assays, it is less expensive than the real-time
RT-PCR studies.
Insummary, throughthiswork, wehavedevelopeda quantita-
tive RT-PCR assay by competition that was sensitive enough to
differentiate among mRNA abundance levels of tiGHR I. The
nature of competition reactions observed was supportive to prove
the authenticity of quantification of tiGHR I.
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Appendix
PROTOCOLS
I- Cloning of competitor
Materials
& RNAgents: Total RNA Isolation System,Promega Z5110
& PolyATract: mRNA Isolation System II, Promega Z5200
& Reverse Transcription System, Promega A3500
& PCR Master Mix, Promega M7505
& QIAquick Gel Extraction Kit, QIAGEN 28704
Competitive RT-PCR Strategy 91& pGEM®-T Easy Vector System I, Promega A1360 and
pBluescript® II Phagemid Vectors, Stratagene 212207 to
cloning DNA sequences
& Reagents for cloning
& Ampicillin and streptomycin for selection purposes
& Degenerated primers to amplify tiGHR I probe sequence
& Top 10 (F
− mcrA Δ[mrr-hsdRMS-mcrBC] ø80 lacZ Δ M15
Δ lacX74deoR recA1 araD139 Δ[ara-leu] 7697 galV galK
rpsL [StrR] endA1nupG) or equivalent electrocompetent E.
coli cells
& T7 RiboMAX TM Express RNAi System, Promega P1700
& MEGAscript® RNAi Kit, Ambion 1626
Methods
1. To obtain total RNA of tilapia (O. niloticus)liver, we followed
the procedure described in the section IV of the Technical
Bulletin 087 (TB087) of RNAgents® Total RNA Isolation
System (Promega). We started with 1 g of tilapia liver.
2. Starting with 5 mg of tilapia liver total RNA, we obtained
mRNA following exactly the protocol described in the sec-
tion IV in the Technical Manual 021 (TM 021, Promega)
to PolyAtract® Systems I.
3. RT-PCR amplifies the tiGHR I probe. The reverse transcrip-
tion reaction was performed with 1 µg of tilapia liver mRNA
and Oligo (dT)15 as primer following the protocol described
in the section III of the Technical Bulletin 099 (TB099) of
Reverse Transcription System (Promega, USA). We used
1 0µ lo ft h ef i v et i m e sd i l u t e dR Tr e a c t i o ni n5 0µ lo ft h e
PCR final volume. We used too 25 µl of PCR Master Mix
2× (Promega) and 3 µM of each degenerated primer
(150 pmol/50 µl PCR). We performed 3 min to 95°C to de-
naturalize all DNAs in the reaction and after we did cycling
program (1 min to 94°C, 1 min to 42°C, and 1 min to
72°C) for 30 cycles and a final extension 5 min to 72°C.
4. Clone the PCR product nearby to 500 bp into the pGEM-
T Easy, or equivalent, vector and transform into electro-
competent top ten E. coli cells, or equivalent, for sequence
verification.
5. Sub-clone the 3′ region of the tiGHR I probe into pBS KS+
vector and ensemble again duplicating an internal Pst I–Acc I
fragment (Fig. 1a).
6. Linearize the plasmid that contains the competitor sequence
under the control of T7 RNA polymerase promoter with ap-
propriated restriction enzyme.
92 Rodríguez-Mallon et al.7. Synthesize single-stranded transcript of competitor RNA. We
followed the protocol described in the section III-C of the
Technical Bulletin 316 of the T7 RiboMax™ Express RNAi
System (Promega)
8. Remove the DNA template by digestion with RNase-free
DNase of the T7 RiboMax™ Express RNAi System.
9. Purification of ssRNA was carried out following the protocol
described in the section III-E of the Instruction Manual of
the MEGAscript® RNAi Kit (Ambion, USA).
10. Quantitatetheproductbymeasuringitsabsorbanceat260nm
and examine the integrity on a 1% denaturing agarose gel.
11. Store RNA competitor precipitated in EtOH at −20°C.
II. Validation of Competitive PCR
Materials
& Linear DNA of target and competitor sequences.
& Gene-specificprimerstoamplifytargetandcompetitorsequence.
& PCR Master Mix, Promega M7505
& Reagents and equipment to do DNA electrophoresis.
& Digital camera Olympus C7070 Wide Zoom
& Image J program (Version 1.33).
Methods
1. Determination of equal PCR amplification efficiency of tar-
get and competitor sequences.
Fig. 7. Densitometry analysis of competitor and target bands using Image J Program. a User-defined
selection from 2% agarose gel digital image. b Image J plots of selected image. c The area measure-
ments displayed in a Results window by the image J Program.
Competitive RT-PCR Strategy 93a. Ensemble ten identical PCR tubes containing equi-
molecular quantities of target and competitor sequences
in 50 µl as final volume. Use 0.2 µM of each specific
primer and 25 µl of PCR Master Mix. Perform 3 min
to 95°C to denature all DNA and a cycling program
30 s to 94°C, 30 s to annealing temperature according
the Tm of the specific oligonucleotides, and 1 min to
72°C. Remove one tube at 17, 19, 21, 24, 27, 30,
33, 36, 39, and 45 cycles, respectively, and store at
−20°C.
b. Electrophoresis in 2% agarose gel in TA 1× (0.04 M
Tris–acetate, 0.001 M EDTA, pH 7) of the amplifica-
tion products of each tube.
c. Take the digital images of the gel.
d. Densitometry analysis of competitor and target bands in
each lane using Image J Program (Version 1.33). This
program is ideal to compare bands in the same digital
image. It is based on the fact that optical density (OD)
is a logarithmic function of brightness. A set of macros
are bundled to Image J which are used for gel densitom-
etry analysis producing curves. The height of the curve,
at any given point, is the mean of the OD of a given
row of pixels in the marked lane. The program can calcu-
late area of user-defined selections. The area measure-
ments are recorded in tabular form and are displayed
in a Results window as shown in Fig. 7. To get more in-
formation, visit http://rsb.info.nih.gov/ij/
e. Plot the area measurements versus cycle number to tar-
get and competitor, respectively (Fig. 3).
f. Calculate efficiency to each cycle to target and competi-
tor as was described in Section 2.
g. Compare the efficiencies of target and competitor using
a paired t test.
h. According to the results, establish 30 cycles for all com-
petitive PCRs.
2. Determination of the sensibility of this method.
a. Ensemble PCRs in the same conditions established be-
fore using decreased quantities of target with different
dilutions of competitor with replicas for each point. In
our experiment, we ensemble:
& 2,000 molecules of target with 750, 1,000, and
5,000 molecules of competitor, respectively.
& 1,000 molecules of target with 500, 1,000, and
5,000 molecules of competitor, respectively.
94 Rodríguez-Mallon et al.& 750 molecules of target with, 250, 750, and 1,000
molecules of competitor, respectively.
& 100 molecules of target with 50, 100, and 500
molecules of competitor, respectively.
& 10 molecules of target with 5, 10, and 50 mole-
cules of competitor, respectively.
b. Electrophoresis in 2% agarose gel in TA 1× (0.04 M
Tris–acetate, 0.001 M EDTA, pH 7) of the amplification
products of each tube.
c. Determination of minimum quantity of target that the
method is able to detect.
3. Characterization of the method precision and repeatability.
a. Ensemble PCRs in the same conditions established before
using quantities of target in the range of your expected
measurements with different dilutions of competitor with
replicas for each point. In our experiment, we ensemble:
& 10
4 m o l e c u l e so fTw i t h5×1 0
3,1 0
4,5×1 0
4,
7.5 × 10
4,a n d1 0
5 molecules of C, respectively,
with three replicas for each point.
& 10
5 molecules of T with 10
4,5×1 0
4, 7.5 × 10
4,
10
5,5×1 0
5,a n d7 . 5×1 0
5 molecules of C, respec-
tively, with three replicas for each point. This ex-
periment was repeated three times in different
days to assay the inter-experiment variability.
& 1.5 × 10
5 molecules of T with the same molecule
quantities of C as the previous experiment with
three replicas for each point.
& 2×1 0
5 molecules of T with 10
3,1 0
4,5×1 0
4,1 0
5,
5×1 0
5, and 10
6 molecules of C, respectively, with
three replicas for each point.
& 10
6moleculesofTwith5×10
5,10
6,5×10
6,and10
7
of C, respectively, with three replicas for each point.
b. Electrophoresis in 2% agarose gel in TA 1× (0.04 M
Tris–acetate, 0.001 M EDTA, pH 7) of the amplification
products of each tube.
c. Take digital images of the gel.
d. Densitometry analysis of competitor and target bands in
each lane using Image J Program (Version 1.33) as was
described in point 1d of this section.
e. Make lineal regressions for each experiment plotting log of
the ratio between the area measurements of C and T versus
log of the C molecule numbers. Determine the equation of
each regression with its respective R2.
Competitive RT-PCR Strategy 95f. Determinethexvalue(Cmoleculenumber)wheny=0.This
condition occurs when the area measurements of C and T are
equal because C/T = 1 and the log1 = 0. Then, x value is
equal to the calculated T molecular number in each experi-
ment.
g. Plot T molecule numbers expected versus observed and
determine the correlation coefficient (r). We used the test
of Pearson correlation. This determination represents a
measure of the precision of our method in the range of
the T quantities assayed.
h. Calculatethevariationcoefficients(CVs)intra-experiment
using the replicas inside experiments and inter-experi-
ments. These CV values characterize the repeatability of
our method in the range of the T quantities assayed.
III. Competitive RT-PCR
Materials
& RNAgents: Total RNA Isolation System, Promega Z5110
& Competitor RNA generated in the Protocol I
& Gene-specificprimerstoamplifytargetandcompetitorsequence.
& Ready-to-Go RT-PCR Beads, Amersham Biosciences, 27-
9259-01
& Reagents and equipment to do DNA electrophoresis.
& Digital camera Olympus C7070 Wide Zoom
& Image J program (Version 1.33).
Methods
1. Isolate total RNA of eight different tissues (brain, muscle,
heart,liver,gonads,stomach,spleen,andintestine)fromthree
tilapias (O. niloticus). Total RNA mini-preparations starting
with 50 mg of each tissue were performed using RNAgents.
Total RNA Isolation System, Promega. (see table 1 of the
TB087).
2. Ensemble reactions of RT-PCR using Ready-to-Go RT-PCR
Beads,AmershamBiosciences.Weused2µlofeachpreparation
of total tissue-specific RNA with at least three known different
quantities of competitor RNA and random primers to the RT
reactions and 0.2 µM of each specific primer to the PCR.
3. Electrophoresis in 2% agarose gel in TA 1× (0.04 M Tris–ac-
etate, 0.001 M EDTA, pH 7) of the amplification products
of each tube.
4. Take digital images of the gel.
96 Rodríguez-Mallon et al.5. Densitometry analysis of competitor and target bands in each
lane using Image J Program (Version 1.33) as was described
in point 1d of this section.
6. Dolinealregressionsforeachexperimentplottinglogoftheratio
between the area measurements of C and T versus log of the C
molecule numbers. Determine the equation of each regression.
7. Determine the x value (C molecule number) when y is equal
to 0. In this condition, x value is equal to T molecule num-
ber in each RNA sample.
8. Normalize this T molecule number in each RNA sample with
the input of total RNA in the RT reaction. The total RNA
input was determined by densitometry analysis of 28S subunit
of ribosomal RNA in each sample using Image J program. We
did an electrophoresis on 1.2% agarose denaturalizing gel of
2 µl of each total RNA preparation. The densitometry data of
the bands corresponding to the 28S subunits measured with
Image J program were converted to micrograms of total
RNAusingareferenceRNAwithknownconcentration.Then,
the results were expressed as tiGHR I molecule numbers/µg
RNAt.
9. Average the tiGHR I molecule numbers/µg RNAt among
the three tilapias to each tissue. These averages were com-
pared by non-parametric Kruskal–Wallis test followed by
Dunn multiple comparison test.
Supplemental
Information
The raw data collection of the 120 amplification reactions
performed to validate our competitive RT-PCR is given in supple-
mentary data file 1. The raw data of the determination of
the tiGHR I levels in each tilapia tissue and their coefficients of
variation can be seen in the supplementary data file 2.
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